Patients Recieving Anti-PD-1 or Anti-PD-L1 Immunotherapies
1 clinical trials · Condition
◉ Watch Patients Recieving Anti-PD-1 or Anti-PD-L1 Immunotherapies
| Record | Firm | Date |
|---|---|---|
| Impact of Immune Checkpoint Inhibitor Therapy on Type 2 Inflammation (NCT04609930) | University Hospital, Montpellier | 2020-10-30 |
Track Patients Recieving Anti-PD-1 or Anti-PD-L1 Immunotherapies automatically
Every clearance here is in the API, with alerts when new ones post.